Business
Covalon to Unveil its SilverCoat(tm) Antimicrobial Silicone Foley Catheter at the 2012 American Urological Association Annual Meeting in Atlanta
MISSISSAUGA, ON, May 18, 2012 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon"...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n\n\n\n\n\nMISSISSAUGA, ON, May 18, 2012 /CNW/ - Covalon Technologies Ltd. (the\n \"Company\" or \"Covalon\") (TSXV: COV), an advanced medical technologies\n company, today announced it will be showcasing  its advanced medical\n coating capabilities, including its SilverCoatTM Antimicrobial Silicone Foley Catheter as well as its recently FDA\n cleared IV Clear™ antimicrobial silicone adhesive film dressing  from\n May 19th to May 23rd at the American Urological Association 2012 Annual Meeting (\"AUA\") in\n Atlanta, Georgia.\n\n\n\"We are looking forward to presenting our SilverCoat™ Antimicrobial\n Silicone Foley Catheter, with its lubricious and antimicrobial coating\n at the AUA,\" said Brian Pedlar, Covalon's Chief Executive Officer. \"We\n have demonstrated that our antimicrobial coating outperforms\n market-leading silver coated Foley catheters in killing the bacteria\n most commonly associated with urinary tract infections. The AUA\n provides Covalon with a great opportunity to showcase our urological\n care products to an international audience, including close to three\n hundred leading manufacturers, wholesalers and distributors.\"\n\n\nUrinary tract infections have been identified by the United States\n Center for Disease Control as the most common type of healthcare\n associated infection, of which 75% are associated with a urinary\n catheter, often referred to as CAUTIs.  The Centers for MediCare and\n Medicaid Services are no longer reimbursing medical institutions for\n the treatment of CAUTIs.\n\n\nNow in its 107th year, the AUA Annual Meeting is the largest gathering\n of urologists in the world, providing unparalleled access to\n groundbreaking research, new guidelines and the latest advances in\n urologic medicine.\n\n\nCovalon will also be showcasing its advanced wound and antimicrobial\n silicone adhesive technology. These exciting new products will be\n available for license or distribution, following regulatory clearance\n to our growing domestic and international distribution channels and to\n medical product companies who are looking to license breakthrough new\n products.\n\n\nTo learn more about Covalon's products and services, please visit us at\n booth 3756 in the Georgia World Congress Center from May 19th to 23rd or contact Brian Pedlar, CEO, Covalon Technologies Ltd. ...